Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1000643210 | 10006432 | 10 | F | 20131126 | 20160328 | 20140313 | 20160331 | EXP | JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-08802NB | BOEHRINGER INGELHEIM | 87.20 | YR | M | Y | 56.10000 | KG | 20160331 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1000643210 | 10006432 | 1 | PS | PRAZAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 220 MG | 22512 | 110 | MG | CAPSULE | BID | ||||||
| 1000643210 | 10006432 | 2 | SS | PRAZAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | 22512 | ||||||||||||
| 1000643210 | 10006432 | 3 | SS | PRAZAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | 22512 | ||||||||||||
| 1000643210 | 10006432 | 4 | SS | BAYASPIRIN | ASPIRIN | 1 | Oral | 100 MG | 0 | 100 | MG | QD | |||||||
| 1000643210 | 10006432 | 5 | C | ARTIST | CARVEDILOL | 1 | Oral | 1.25 MG | 0 | 1.25 | MG | TABLET | QD | ||||||
| 1000643210 | 10006432 | 6 | C | TANATRIL | IMIDAPRIL | 1 | Oral | 0 | TABLET | QD | |||||||||
| 1000643210 | 10006432 | 7 | C | LANSOPRAZOLE OD | LANSOPRAZOLE | 1 | Oral | 0 | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1000643210 | 10006432 | 1 | Atrial fibrillation |
| 1000643210 | 10006432 | 2 | Cerebrovascular accident prophylaxis |
| 1000643210 | 10006432 | 3 | Thrombosis prophylaxis |
| 1000643210 | 10006432 | 4 | Prophylaxis |
| 1000643210 | 10006432 | 5 | Product used for unknown indication |
| 1000643210 | 10006432 | 6 | Product used for unknown indication |
| 1000643210 | 10006432 | 7 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1000643210 | 10006432 | DE |
| 1000643210 | 10006432 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1000643210 | 10006432 | Cardiac failure | |
| 1000643210 | 10006432 | Cardio-respiratory arrest | |
| 1000643210 | 10006432 | Dehydration | |
| 1000643210 | 10006432 | Gastrointestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 1000643210 | 10006432 | 1 | 20131125 | 20131129 | 0 | |
| 1000643210 | 10006432 | 4 | 20131126 | 20131129 | 0 | |
| 1000643210 | 10006432 | 5 | 20131126 | 20131129 | 0 | |
| 1000643210 | 10006432 | 6 | 20131126 | 20131129 | 0 | |
| 1000643210 | 10006432 | 7 | 20131126 | 20131129 | 0 |